Reports
Sale
Global Influenza Diagnostics Market Share, Size, Growth, Analysis, Report, Forecast: By Test Type: Traditional Diagnostic Test, Molecular Diagnostic Assay; By Product: Test Kits, Instruments; By End User: Hospitals, Diagnostic Laboratories, Research Laboratory, Others; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Influenza Diagnostics Market Outlook
The global influenza diagnostics market size attained a value of USD 780.6 million in 2023. The market is further expected to grow at a CAGR of 9% during the forecast period of 2024-2032 to reach USD 1695.3 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Influenza Diagnostics Market: Introduction and Insights
Influenza diagnostics are used to detect the presence of influenza viruses as the symptoms can be very similar to other virus or flu. The common symptoms of the condition include headache, sore throat, fever, runny nose, dry cough, nasal congestion, muscle aches and lack of energy, among others. These signs and symptoms of the condition can differ from person to person, depending on their age and immune system. Diagnostics are important to determine the presence of the virus.
The influenza diagnostics market is being driven by the accelerating prevalence of influenza, the rise in research funding for influenza diagnostics, and the increasing demand for faster diagnosis and management of influenza. Influenza diagnostics help determine if a person is suffering from influenza by detecting the influenza viral nucleoprotein antigen. These are commercially available and help provide results in as less as 30 minutes span, exhibiting colour change or other visual signals.
Influenza Diagnostics Market Segmentations
The market is categorised into segments like test type, product, end user, and region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Test Type
- Traditional Diagnostic Test
- Rapid Influenza Diagnostic Test (RIDT)
- Viral Culture
- Direct Fluorescent Antibody (DFA) Test
- Serological Assay
- Molecular Diagnostic Assay
- Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
- Nucleic Acid Sequence-Based Amplification (NASBA) Test
- Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
- Simple Amplification-Based Assay (SAMBA)
- Others
Market Breakup by Product
- Test Kits
- Instruments
Market Breakup by End User
- Hospitals
- Diagnostic Laboratories
- Research Laboratory
- Others
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Influenza Diagnostics Market Analysis
The influenza diagnostics market growth is being driven by the rising prevalence of influenza over the forecast period. The growing awareness among the population about the early diagnosis and effective treatment of influenza is aiding the market growth. It is also recommended for all patients with suspected influenza, thus, further enhancing the influenza diagnostics industry. The growth of the market is positively influenced by the rising funding for influenza diagnosis, research, and treatment. The disease can further degrade the health and develop further complications in individuals like pneumonia, bronchitis, asthma flare-ups, heart problems, and an ear infection, among others, creating an immediate need for influenza diagnostic and treatments, further propelling the influenza diagnostics market forward.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global influenza diagnostics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Abbott Laboratories
- Becton, Dickinson and Company
- Coris BioConcept
- DiaSorin SpA
- F. Hoffmann-La Roche Ltd.
- Luminex Corporation
- Meridian Bioscience Inc.
- Quidel Corporation
- Sekisui Diagnostics
- Thermo Fisher Scientific Inc.
- Hologic, Inc.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Product |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Influenza Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Influenza Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Influenza Epidemiology (2016-2031)
5.3 Europe Influenza Epidemiology (2016-2031)
5.4 Asia Pacific Influenza Epidemiology (2016-2031)
5.5 Latin America Influenza Epidemiology (2016-2031)
5.6 Middle East and Africa Influenza Epidemiology (2016-2031)
6 Global Influenza Diagnostic Market Overview
6.1 Global Influenza Diagnostic Market Historical Value (2017-2023)
6.2 Global Influenza Diagnostic Market Forecast Value (2024-2032)
7 Global Influenza Diagnostic Market Landscape
7.1 Influenza Diagnostic: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Influenza Diagnostic: Product Landscape
7.2.1 Analysis by Test Type
7.2.2 Analysis by Product
7.2.3 Analysis by End User
8 Influenza Diagnostic Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Influenza Diagnostic Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Influenza Diagnostic Market Segmentation
11.1 Global Influenza Diagnostic Market by Test Type
11.1.1 Market Overview
11.1.2 Traditional Diagnostic Test
11.1.2.1 Rapid Influenza Diagnostic Test (RIDT)
11.1.2.2 Viral Culture
11.1.2.3 Direct Fluorescent Antibody (DFA) Test
11.1.2.4 Serological Assay
11.1.3 Molecular Diagnostic Assay
11.1.3.1 Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
11.1.3.2 Nucleic Acid Sequence-Based Amplification (NASBA) Test
11.1.3.3 Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
11.1.3.4 Simple Amplification-Based Assay (SAMBA)
11.1.3.5 Others
11.2 Global Influenza Diagnostic Market by Product
11.2.1 Market Overview
11.2.2 Test Kits
11.2.3 Instruments
11.3 Global Influenza Diagnostic Market by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Diagnostic Laboratories
11.3.4 Research Laboratory
11.3.5 Others
11.4 Global Influenza Diagnostic Market by Region
11.4.1 Market Overview
11.4.2 North America
11.4.3 Europe
11.4.4 Asia Pacific
11.4.5 Latin America
11.4.6 Middle East and Africa
12 North America Influenza Diagnostic Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Influenza Diagnostic Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Influenza Diagnostic Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Influenza Diagnostic Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Influenza Diagnostic Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Abbott Laboratories
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Becton, Dickinson and Company
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Coris BioConcept
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 DiaSorin SpA
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 F. Hoffmann-La Roche Ltd.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Luminex Corporation
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Meridian Bioscience Inc.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Quidel Corporation
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Sekisui Diagnostics
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Thermo Fisher Scientific Inc.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Hologic, Inc.
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
24 Influenza Diagnostic - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global market size attained a value of USD 780.6 million in 2023.
The market is further expected to grow at a CAGR of 9% during the forecast period of 2024-2032 to reach USD 1695.3 million by 2032.
The major growth drivers of the market include the accelerating prevalence of influenza, the rise in research funding for influenza diagnostics, and the increasing demand for faster diagnosis and management of the disease.
The key trends guiding the market growth include the rising funding for influenza diagnosis, research, and treatment.
The major regional markets include North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The test types include traditional diagnostic test and molecular diagnostic assay.
The product types in the market comprise of test kits and instruments.
The end-users in the market include hospitals, diagnostic laboratories, and research laboratory, among others.
The key players in the market include Abbott Laboratories, Becton, Dickinson and Company, Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, Thermo Fisher Scientific Inc., and Hologic, Inc., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER